SS
SANA icon

SBI Securities’s Sana Biotechnology SANA Stock Holding History

SBI Securities’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.79K Buy
2,233
+105
+5% +$338 ﹤0.01% 1962
2026
Q1 		$6.13K Buy
2,128
+490
+30% +$1.93K ﹤0.01% 1940
2025
Q4 		$6.67K Sell
1,638
-3,210
-66% -$14.4K ﹤0.01% 1908
2025
Q3 		$17.2K Buy
4,848
+1,510
+45% +$5.46K ﹤0.01% 1518
2025
Q2 		$9.11K Buy
3,338
+999
+43% +$2.06K ﹤0.01% 1739
2025
Q1 		$3.93K Buy
2,339
+186
+9% +$520 ﹤0.01% 1995
2024
Q4 		$3.51K Buy
+2,153
New +$6.42K ﹤0.01% 2063

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

SBI Securities's SANA Position: Q2 2026 in Review

SBI Securities increased its Sana Biotechnology (SANA) stake by 4.9% in Q2 2026, buying an estimated $338 and bringing the position to 2,233 shares worth $7.79K. The position accounts for ﹤0.01% of the portfolio, ranked #1962.

SBI Securities first reported a position in SANA in Q4 2024 and has held it in 7 quarters since. The position peaked at $17.2K in Q3 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • SBI Securities held 2,233 shares of Sana Biotechnology worth $7.79K as of Q2 2026.
  • SBI Securities bought 105 Sana Biotechnology shares in Q2 2026, an estimated $338.
  • Sana Biotechnology made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1962 holding.
  • SBI Securities first reported a position in Sana Biotechnology in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Sana Biotechnology position peaked at $17.2K in Q3 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.